SIGNAL GENETICS, INC. 4
4 · SIGNAL GENETICS, INC. · Filed Nov 2, 2016
Insider Transaction Report
Form 4
Riccitelli Samuel D
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2016-10-31+200,000→ 674,530 total - Tax Payment
Common Stock
2016-10-31$0.36/sh−103,160$37,138→ 571,370 total - Exercise/Conversion
Restricted Stock Units
2016-10-31−200,000→ 0 totalExercise: $0.00→ Common Stock (200,000 underlying)
Footnotes (3)
- [F1]The restricted stock units reported herein converted into common stock on a one-for-one basis.
- [F2]Shares withheld to satisfy tax withholding obligations.
- [F3]On March 28, 2016, the reporting person was granted 200,000 restricted stock units. In connection with the execution of the Agreement and Plan of Merger and Reorganization, dated October 31, 2016, by and among Signal Genetics, Inc. (the "Issuer"), Signal Merger Sub, Inc. and Miragen Therapeutics, Inc. (the "Merger Agreement"), the Compensation Committee of the Issuer's Board of Directors accelerated the vesting of these restricted stock units in full.